Prevention of disabling and fatal strokes by successful carotid endarter- ectomy in patients without recent neurological symptoms: randomised controlled trial [published correction appears in Lancet. 2004;364:416]. Lancet. 2004;363:1491 1502. 414. Mas JL, Trinquart L, Leys D, Albucher JF, Rousseau H, Viguier A, Bossavy JP, Denis B, Piquet P, Garnier P,Viader F, Touz E, Julia P, Giroud M, Krause D, Hosseini H, Becquemin JP, Hinzelin G, Houdart E, H non H, Neau JP, Bracard S, Onnient Y, Padovani R, Chatellier G; EVA-3S Investigators. Endarterectomy Versus Angioplasty in Patients with Symptomatic Severe Carotid Stenosis (EVA-3S) trial: results up to 4 years from a randomised, multicentre trial. Lancet Neurol. 2008;7:885 892. 415. Eckstein HH, Ringleb P, Allenberg JR, Berger J, Fraedrich G, Hacke W, Hennerici M, Stingele R, Fiehler J, Zeumer H, Jansen O. Results of the Stent-Protected Angioplasty versus Carotid Endarterectomy (SPACE) study to treat symptomatic stenoses at 2 years: a multinational, prospec- tive, randomised trial [published correction appears in Lancet Neurol. 2009;8:135]. Lancet Neurol. 2008;7:893 902. 416. Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Stenting versus endarterectomy for treatment of carotid-artery stenosis [published corrections appear in N Engl J Med. 2010;363:198 and N Engl J Med. 2010;363:498]. N Engl J Med. 2010;363:11 23. 417. Taylor DW, Barnett HJ, Haynes RB, Ferguson GG, Sackett DL, Thorpe KE, Simard D, Silver FL, Hachinski V, Clagett GP, Barnes R, Spence JD; for the ASA and Carotid Endarterectomy (ACE) Trial Collaborators. Low- dose and high-dose acetylsalicylic acid for patients undergoing carotid end- arterectomy: a randomised controlled trial. Lancet. 1999;353:2179 2184. 418. 